Groups seek clar­i­ty on in­ter­change­abil­i­ty in Bs­U­FA III

Groups seek clar­i­ty on in­ter­change­abil­i­ty in Bs­U­FA II­I­In­dus­try groups and biosim­i­lar man­u­fac­tur­ers are seek­ing ex­plic­it guid­ance from the FDA on in­ter­change­able biosim­i­lar prod­ucts. The …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER